Recall Register

Food, drugs, devices › Hi-Tech Pharmacal Co., Inc.

Drug recall: BUCALSEP (R) ORAL SOLUTION, (Benzocaine, 600 mg, Cetylpyridinum Chloride 30 mg, Menthol 45 mg Zinc Chloride 30 mg), 1 Fl

FDA enforcement event 64857 · Class III · initiated 8 Apr 2013 · status Terminated · terminated 30 Apr 2015

DrugVoluntary: Firm initiated1 product recordAmityville, NY

FDA enforcement event 64857 is a drug recall by Hi-Tech Pharmacal Co., Inc. of Amityville, NY, initiated 8 Apr 2013 and classified Class III, with 1 product record.

FDA defines Class III as a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences. 26% of the 370 drug enforcement events initiated in 2013 carry the same class.

Status: Terminated, terminated 30 Apr 2015. Initiation: voluntary: firm initiated. Hi-Tech Pharmacal Co., Inc. has 10 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Hi-Tech Pharmacal Co., Inc., Amityville, NY.

Reason for recall

"Subpotent; Cetylpyridinum Chloride"

Distribution

"Puerto Rico"

Product records

Recall numberProductQuantityClassStatusReport date
D-418-2013BUCALSEP (R) ORAL SOLUTION, (Benzocaine, 600 mg, Cetylpyridinum Chloride 30 mg, Menthol 45 mg Zinc Chloride 30 mg), 1 Fl. Oz. (30 mL), Manufactured for GIL PHARMACEUTICAL CORP, PONCE, PUERTO RICO 00717-1565 -- NDC 58552-103-0110,440 bottlesClass IIITerminated22 May 2013

Context

26%of 2013 drug events are Class III370 events that year
1product record in this eventfirm median: 1
10events on this register for the firm

Other enforcement events for Hi-Tech Pharmacal Co., Inc.

InitiatedProduct (first record)TypeClassRecords
23 Dec 2014FERROUS SULFATE ELIXIR 220 mg/5 mL, UPC 350838778059, NDC 50383-778-05 --- HI-TECH PHARMACAL CO, INC. AMITYVILLE, NY 117FoodClass II1
25 Aug 2014Rx CHOICE brand LIQUID VITAMIN C, 16 FL OZ (473 mL), NDC 50383-167-16 --- HI-TECH PHARMACAL CO., INC. Amityville, NY 117FoodClass III1
28 Jul 2014Rx CHOICE brand LIQUID VITAMIN C, 16 FL OZ (473 mL), NDC 50383-167-16 --- HI-TECH PHARMACAL CO., INC. Amityville, NY 117FoodClass III1
1 Apr 2014HydrOXYzine Hydrochloride Oral Solution, USP, 10 mg / 5mL, Net Wt 16 fl oz (473 mL), NDC 50383-796-16, Rx Only, ManufactDrugClass II1
28 Oct 2013Acyclovir Oral Suspension, USP 200 mg/5 mL, Net Wt. 16 fl oz (473 mL), Rx only, Hi-Tech Pharmacal Co, Inc. Amityville, NDrugClass III1
4 Sep 2013GILTUSS ANTITUSSIVE EXPECTORANT AND NASAL DECONGESTANT, 1 fl. oz. (NDC 58552-122-01) and 8 fl. oz. (NDC 58552-122-08), aDrugClass III1
25 Jul 2013Clobetasol Propionate Cream, USP, 0.05%, 15 grams, Rx only, Hi-Tech PHARMACAL label, Hi-Tech Pharmacal, Co., Inc., AmityDrugClass III1
30 Apr 2013HydrOXYzine Hydrochloride Oral Solution, USP, 10 mg/5 mL, 16 fl. oz. (473 mL), Rx Only, HI-TECH PHARMACAL CO., INC. AMITDrugClass III1
11 Mar 2013Acetic Acid Otic Solution, USP, 15 mL bottle, Rx Only, Hi-Tech Pharmacal Co., Inc., Amityville, N.Y. 11701, NDC 50383-88DrugClass III1

All 10 events for Hi-Tech Pharmacal Co., Inc.

Questions and answers

Why was this drug recalled?

FDA's record gives the reason for recall as: "Subpotent; Cetylpyridinum Chloride"

What does Class III mean?

FDA classifies recalls by relative degree of health hazard. Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.

Where was the product distributed?

FDA's distribution pattern field reads: "Puerto Rico"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 30 Apr 2015. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA drug enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.